非酒精性脂肪性肝病中尽管初级和次级胆汁酸生成增加但肝脏胆汁酸信号受抑制
该研究检测了非酒精性脂肪性肝病(NAFLD)患者、高脂饮食喂养大鼠及对照组的血清胆汁酸水平、成纤维细胞生长因子19(FGF19)、肝脏基因表达谱和肠道微生物组组成。结果显示NAFLD中初级和次级胆汁酸血清浓度升高,法尼醇X受体(FXR)拮抗性脱氧胆酸(DCA)百分比升高而激动性鹅去氧胆酸(CDCA)降低,血清FGF19降低,提示FXR和成纤维细胞生长因子受体4(FGFR4)介导的信号受损。结论认为NAFLD中胆汁酸生成增加,FXR拮抗性胆汁酸比例增加至少部分解释了肝脏FXR和FGFR4信号受抑制。
要点
- NAFLD患者血清初级和次级胆汁酸浓度升高,DCA百分比升高而CDCA降低。
- NAFLD中肝脏FXR和FGFR4介导的信号受损,表现为血清FGF19降低。
- NAFLD患者肠道中牛磺酸和甘氨酸代谢细菌增加,反映次级胆汁酸生成增加。
核心结论
- 血清胆汁酸谱、肝脏基因表达模式和肠道微生物组组成一致支持NAFLD中胆汁酸生成增加。
- FXR拮抗性胆汁酸比例增加至少部分解释了肝脏FXR介导和FGFR4介导信号的抑制。
- 研究提示未来NAFLD干预可能靶向FXR信号组分,包括胆汁酸转化的肠道微生物组。
研究设计与样本
- 研究检测了NAFLD患者、高脂饮食喂养大鼠及其对照组的血清胆汁酸水平和FGF19、肝脏基因表达谱及肠道微生物组组成。
主要发现
- NAFLD患者血清初级和次级胆汁酸浓度升高。
- NAFLD中FXR拮抗性DCA百分比升高,而激动性CDCA百分比降低。
- NAFLD中细胞色素P450 7A1、Na+-牛磺胆酸共转运多肽和对氧磷酶1的mRNA表达增加,小异二聚体伴侣和胆盐输出泵的mRNA表达无变化,血清FGF19降低,为FXR和FGFR4介导信号受损的证据。
- NAFLD患者肠道中牛磺酸和甘氨酸代谢细菌增加,反映次级胆汁酸生成增加。
- 高脂饮食喂养大鼠中观察到相似的肝脏基因表达和肠道微生物组变化。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Bile acids are regulators of lipid and glucose metabolism, and modulate inflammation in the liver and other tissues. Primary bile acids such as cholic acid and chenodeoxycholic acid (CDCA) are produced in the liver, and converted into secondary bile acids such as deoxycholic acid (DCA) and lithocholic acid by gut microbiota. Here we investigated the possible roles of bile acids in non-alcoholic fatty liver disease (NAFLD) pathogenesis and the impact of the gut microbiome on bile acid signalling in NAFLD. DESIGN: Serum bile acid levels and fibroblast growth factor 19 (FGF19), liver gene expression profiles and gut microbiome compositions were determined in patients with NAFLD, high-fat diet-fed rats and their controls. RESULTS: Serum concentrations of primary and secondary bile acids were increased in patients with NAFLD. In per cent, the farnesoid X receptor (FXR) antagonistic DCA was increased, while the agonistic CDCA was decreased in NAFLD. Increased mRNA expression for cytochrome P450 7A1, Na+-taurocholate cotransporting polypeptide and paraoxonase 1, no change in mRNA expression for small heterodimer partner and bile salt export pump, and reduced serum FGF19 were evidence of impaired FXR and fibroblast growth factor receptor 4 (FGFR4)-mediated signalling in NAFLD. Taurine and glycine metabolising bacteria were increased in the gut of patients with NAFLD, reflecting increased secondary bile acid production. Similar changes in liver gene expression and the gut microbiome were observed in high-fat diet-fed rats. CONCLUSIONS: The serum bile acid profile, the hepatic gene expression pattern and the gut microbiome composition consistently support an elevated bile acid production in NAFLD. The increased proportion of FXR antagonistic bile acid explains, at least in part, the suppression of hepatic FXR-mediated and FGFR4-mediated signalling. Our study suggests that future NAFLD intervention may target the components of FXR signalling, including the bile acid converting gut microbiome.
引用
- Jiao N, Baker SS, Chapa-Rodriguez A, et al. Suppressed hepatic bile acid signalling despite elevated production of primary and secondary bile acids in NAFLD. Gut. 2017. PMID: 28774887. doi:10.1136/gutjnl-2017-314307
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。